Literature DB >> 11182857

Drug-induced thrombocytopenia: an updated systematic review.

M A Rizvi, K Kojouri, J N George.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11182857     DOI： 10.7326/0003-4819-134-4-200102200-00030

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced thrombocytopenia: an updated systematic review, 2006.

Authors:  Xiaoning Li; Karen K Swisher; Sara K Vesely; James N George
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Drug-induced thrombocytopenia: an updated systematic review, 2008.

Authors:  Karen K Swisher; Xiaoning Li; Sara K Vesely; James N George
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Drug-induced thrombocytopenia: a population study.

Authors:  Maarten J ten Berg; Albert Huisman; Patrick C Souverein; Alfred F A M Schobben; Antoine C G Egberts; Wouter W van Solinge; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

Authors:  S M Said; J Hahn; E Schleyer; M Müller; G M Fiedler; M Buerke; R Prondzinsky
Journal:  Clin Res Cardiol       Date:  2006-12-08       Impact factor: 5.460

Review 5.  Drug-induced immune thrombocytopenia.

Authors:  Patricia M L A van den Bemt; Ronald H B Meyboom; Antoine C G Egberts
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Profound thrombocytopenia after primary exposure to eptifibatide.

Authors:  Nicholas B Norgard; Brian T Badgley
Journal:  Drug Healthc Patient Saf       Date:  2010-09-21

7.  Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia.

Authors:  Amer Aljundi; Alaa Rahhal; Wafer Dabdoob
Journal:  Case Rep Cardiol       Date:  2020-06-09

8.  Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial.

Authors:  Todd C Lee; Emily G McDonald; Zahra N Sohani; Guillaume Butler-Laporte; Andrew Aw; Sara Belga; Andrea Benedetti; Alex Carignan; Matthew P Cheng; Bryan Coburn; Cecilia T Costiniuk; Nicole Ezer; Dan Gregson; Andrew Johnson; Kosar Khwaja; Alexander Lawandi; Victor Leung; Sylvain Lother; Derek MacFadden; Michaeline McGuinty; Leighanne Parkes; Salman Qureshi; Valerie Roy; Barret Rush; Ilan Schwartz; Miranda So; Ranjani Somayaji; Darrell Tan; Emilie Trinh
Journal:  BMJ Open       Date:  2022-07-21       Impact factor: 3.006

9.  Case report: vancomycin-induced thrombocytopenia in a burn patient.

Authors:  Ronald Pauldine; Aliaksei Pustavoitau
Journal:  Eplasty       Date:  2008-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.